How Bayer Secured the Top-Spot in China: An Interview with Liam Condon

A focus on older, primary care brands--initially running contrary to Bayer Schering's group strategy post-merger--was key to the company's reaching its leadership position in China. Liam Condon, Managing Director of Bayer HealthCare China, talks about the group's commercial success to date and its future plans, particularly to build up its R&D presence.